ArticleACS ES&T water2026
Hydrogeologic Drivers and Management Implications of PFAS, Nitrate, and Pharmaceuticals in Groundwater at a Karst Beneficial Reuse System.
Article in ACS ES&T water, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Management of beneficial reuse sites typically focuses on controlling the fate and transport of conventional water quality parameters, particularly nitrogen. However, it is unclear if current management is also effective for controlling contaminants with distinct physiochemical properties, such as pharmaceuticals and per- and polyfluoroalkyl substances (PFAS). We investigated the spatial and temporal patterns of nitrate, PFAS, and pharmaceuticals in groundwater monitoring wells at a beneficial reuse site. These data sets were integrated with hydrogeologic variables, including groundwater elevation, rainfall, surface karst features, wastewater inputs, and irrigation intensity, to compare drivers of occurrence, fate, and transport behavior across classes of contaminants. Additionally, we evaluated the suitability of a modified version of a groundwater vulnerability model for predicting spatial patterns of PFAS and pharmaceuticals. Overall, pharmaceuticals exhibited lower detection frequencies, higher temporal variability, and spatial patterns distinct from nitrate and PFAS. Their episodic occurrence responded strongly to wastewater inputs and rarely exceeded criteria for antibiotic resistance. In contrast, PFAS and nitrate concentrations fluctuated primarily with groundwater elevation and were well-aligned with groundwater vulnerability predictions. Results suggest that reuse management should target periods of high rainfall and consumer use to reduce pharmaceutical inputs, whereas nitrate and PFAS management should be informed by groundwater conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.